English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17933/22952 (78%)
Visitors : 7335357      Online Users : 554
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/17729


    Title: Application of machine learning to predict the recurrence-proneness for cervical cancer
    Authors: Tseng, Chih-Jen
    Lu, Chi-Jie
    Chang, Chi-Chang
    Chen, Gin-Den
    Contributors: 中山醫大
    Keywords: Recurrent cervical cancer;Support vector machine;Extreme learning machine;C5.0
    Date: 2014
    Issue Date: 2017-06-01T07:32:10Z (UTC)
    ISSN: 0941-0643
    Abstract: This study applied advanced machine learning techniques, widely considered as the most successful method to produce objective to an inferential problem of recurrent cervical cancer. Traditionally, clinical diagnosis of recurrent cervical cancer was based on physician’s clinical experience with various risk factors. Since the risk factors are broad categories, years of clinical study and experience have tried to identify key risk factors for recurrence. In this study, three machine learning approaches including support vector machine, C5.0 and extreme learning machine were considered to find important risk factors to predict the recurrence-proneness for cervical cancer. The medical records and pathology were accessible by the Chung Shan Medical University Hospital Tumor Registry. Experimental results illustrate that C5.0 model is the most useful approach to the discovery of recurrence-proneness factors. Our findings suggest that four most important recurrence-proneness factors were Pathologic Stage, Pathologic T, Cell Type and RT Target Summary. In particular, Pathologic Stage and Pathologic T were important and independent prognostic factor. To study the benefit of adjuvant therapy, clinical trials should randomize patients stratified by these prognostic factors, and to improve surveillance after treatment might lead to earlier detection of relapse, and precise assessment of recurrent status could improve outcome.
    URI: http://dx.doi.org/10.1007/s00521-013-1359-1
    https://ir.csmu.edu.tw:8080/ir/handle/310902500/17729
    Relation: Neural Computing and Applications May 2014, Volume 24, Issue 6, pp 1311–1316
    Appears in Collections:[應用資訊科學學系暨碩士班] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML316View/Open


    SFX Query

    All items in CSMUIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback